ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 696073 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 696073; 2) Community: the network communities that were significantly associated with the response to NSC 696073; 3) Molecule: the relationships between components within communities and NSC 696073; 4) MDR: the compounds that were significantly associated with the NSC 696073.

NSC Compound Enrichment Correlation
NSC 753394 3-[2-(5-fluoro-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0219468083770723 0.26208738
NSC 759857 Clofarabine (USAN) 0.0219468083770723 -0.038128254
NSC 762542 Null 0.0219468083770723 0.09934064
NSC 716223 Null 0.0221886141818656 0.13572467
NSC 732832 1-{2-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrol ylamino)phenylcarboxamido]ethyl}-3,4-dimethoxybenzene 0.0221886141818656 0.2223919
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.022188614181866 0.20002545
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.022188614181866 0.13610279
NSC 300289 Pinafide 0.022188614181866 0.22188143
NSC 328410 Camptothecin Derivative 0.022188614181866 0.078416021
NSC 606497 Camptothecin Derivative 0.022188614181866 0.012083445
Total:66  Current:33    [First] [Prev] [Next] [Last]